Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 145.46B KRW in the quarter ending September 30, 2025, a decrease of -6.73%. This brings the company's revenue in the last twelve months to 575.66B, down -5.67% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.

• Revenue (ttm): 575.66B
• Revenue Growth: -5.67%
• P/S Ratio: 1.64
• Revenue / Employee: 542.56M
• Employees: 1,061
• Market Cap: 946.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	614.94B	14.18B	2.36%
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	561.85B	44.38B	8.58%